Skip to content

Hv Curran

13 papers in the library · 1,262 citations · publishing 2008-2026

Papers

Sort Most recent Most cited

Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation

PLoS One June 18, 2026 Elisa Liberati, Hv Curran, Peter Fonagy et al.

INTRODUCTION: Methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA-AP) is a potentially transformative intervention for post-traumatic stress disorder (PTSD). Despite encouraging Phase III trial results, the psychological mechanisms underpinning MDMA's therapeutic effects remain insufficiently understood. Existing research on MDMA has emphasised neurobiological processes but has...

DOI: 10.1371/journal.pone.0350728 (opens in new tab) MDMA Grounded theory Interpretative phenomenological analysis Thematic analysis +14

Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attendees.

International Journal of Drug Policy February 9, 2022 Meryem Grabski, Jon Waldron, Tom P. Freeman et al.

BACKGROUND Esketamine was licensed for use in treatment resistant depression by the European Medicines Agency in December 2019. It is unclear whether this new approval has lowered the risk perception of recreational ketamine use. This is important given a recent increase in recreational ketamine use. METHODS This study expanded on an existing longitudinal online study of the nightlife scene, by...

How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.

Neuroscience & Biobehavioral Reviews September 30, 2019 A. Freeman, Kat Petrilli, Rachel Lees et al.

The recent liberalisation of cannabis regulation has increased public and scientific debate about its potential benefits and risks. A key focus has been the extent to which cannabidiol (CBD) might influence the acute effects of delta-9-tetrahydrocannabinol (THC), but this has never been reviewed systematically. In this systematic review of how CBD influences the acute effects of THC we...

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Psychopharmacology November 8, 2017 R. L. Carhart-Harris, Mark Bolstridge, C. M. J. Day et al. 978 citations

RATIONALE: Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. OBJECTIVES: Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. METHODS: Twenty patients (six females) with (mostly) severe, unipolar, treatment-resistant major...

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

Psychopharmacology October 30, 2017 J. B. Stroud, Tom P. Freeman, Robert Leech et al. 102 citations

RATIONALE: Depressed patients robustly exhibit affective biases in emotional processing which are altered by SSRIs and predict clinical outcome. OBJECTIVES: The objective of this study is to investigate whether psilocybin, recently shown to rapidly improve mood in treatment-resistant depression (TRD), alters patients' emotional processing biases. METHODS: Seventeen patients with...

Salience attribution and its relationship to cannabis-induced psychotic symptoms.

Psychological Medicine December 2016 Michael Bloomfield, E Mouchlianitis, C J A Morgan et al.

Cannabis is a widely used drug associated with increased risk for psychosis. The dopamine hypothesis of psychosis postulates that altered salience processing leads to psychosis. We therefore tested the hypothesis that cannabis users exhibit aberrant salience and explored the relationship between aberrant salience and dopamine synthesis capacity. We tested 17 cannabis users and 17 age- and...

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers.

Translational Psychiatry February 16, 2016 C J A Morgan, Tom P. Freeman, J Powell et al.

Smoking cannabis daily doubles an individual's risk of developing a psychotic disorder, yet indicators of specific vulnerability have proved largely elusive. Genetic variation is one potential risk modifier. Single-nucleotide polymorphisms in the AKT1 and catechol-O-methyltransferase (COMT) genes have been implicated in the interaction between cannabis, psychosis and cognition, but no studies...

LSD enhances the emotional response to music.

Psychopharmacology October 2015 Mendel Kaelen, Frederick S. Barrett, Leor Roseman et al.

There is renewed interest in the therapeutic potential of psychedelic drugs such as lysergic acid diethylamide (LSD). LSD was used extensively in the 1950s and 1960s as an adjunct in psychotherapy, reportedly enhancing emotionality. Music is an effective tool to evoke and study emotion and is considered an important element in psychedelic-assisted psychotherapy; however, the hypothesis that...

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

Biological Psychiatry January 10, 2014 Robin Carhart-Harris, Kevin Murphy, Robert Leech et al. 182 citations

The MTLs appear to be specifically implicated in the mechanism of action of MDMA, but further work is required to elucidate how the drug's characteristic subjective effects arise from its modulation of spontaneous brain activity.

DOI: 10.1016/j.biopsych.2013.12.015 (opens in new tab) MDMA Euphoriant Cerebral blood flow Amygdala +5

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being

Psychological Medicine February 1, 2012 C. J. A. Morgan, Chelsea Gardener, G. Schafer et al.

Background Cannabis varies considerably in levels of its two major constituent cannabinoids – (delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Recently, we found evidence that those who smoked cannabis containing detectable levels of CBD had fewer psychotic-like symptoms than those whose cannabis had no CBD. The present study aimed, first, to replicate those findings and, second, to...

Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions.

Drug and Alcohol Dependence November 1, 2010 Bradley Platt, Sunjeev K. Kamboj, C. Morgan et al.

BACKGROUND While heavy cannabis-users seem to show various cognitive impairments, it remains unclear whether they also experience significant deficits in affective functioning. Evidence of such deficits may contribute to our understanding of the interpersonal difficulties in cannabis-users, and the link between cannabis-use and psychological disorders (Moore et al., 2007). METHOD Emotion...

Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis

Psychological Medicine June 1, 2009 O. Mason, C. J. A. Morgan, S. K. Dhiman et al.

BackgroundEpidemiological evidence suggests a link between cannabis use and psychosis. A variety of factors have been proposed to mediate an individual's vulnerability to the harmful effects of the drug, one of which is their psychosis proneness. We hypothesized that highly psychosis-prone individuals would report more marked psychotic experiences under the acute influence of cannabis.MethodA...

Journey through the K-hole: phenomenological aspects of ketamine use.

Drug and Alcohol Dependence March 19, 2008 L Muetzelfeldt, Sunjeev K. Kamboj, H Rees et al.

Although recreational use of the dissociative anaesthetic drug ketamine is currently increasing, little is known about the phenomenological aspects of its use. We therefore designed a structured interview to examine initiation experiences, positive and negative effects of ketamine use, and concerns about the drug and its long-term effects. Ninety participants (30 frequent users, 30 infrequent...

DOI: 10.1016/j.drugalcdep.2008.01.024 (opens in new tab) Ketamine Humans Substance-related disorders Attitude +6